BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 153779)

  • 1. [Hormonal dynamics during pregnancy: critical discussion and clinical interpretations].
    Bélisle S
    Can Med Assoc J; 1978 Dec; 119(11):1307-9. PubMed ID: 153779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol and estetrol plasma levels before and after intravenous administration of dehydroepiandrosterone sulfate in normal and pathologic pregnancies.
    De Cecco L; Capitanio GL; Lanera P; Pedretti E; Ragni N; Rossato P; Venturini PL
    Acta Eur Fertil; 1979 Mar; 10(1):1-13. PubMed ID: 161846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of the dynamic dehydroepiandrosterone-test compared to the static measurement of total urinary estrogen excretion in the diagnosis of the condition of the feto-placental-unit (author's transl)].
    Kraus H; Lauritzen C; Schneider A; Neumann GK
    Z Geburtshilfe Perinatol; 1976 Oct; 180(5):324-33. PubMed ID: 135421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the clinical evaluation of DHAS loading as a fetoplacental function test--effect of DHAS on estrogen metabolism at a fetoplacental unit].
    Kiriyama T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):700-8. PubMed ID: 2941503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroepiandrosterone sulphate loading test and determination of plasma oestetrol concentration in late pregnancy.
    Schollberg K; Seiler E; Wagner S
    Exp Clin Endocrinol; 1985 Apr; 85(2):204-8. PubMed ID: 3160598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DHEA-S-loading test in cases of intrauterine growth retardation: relationship between the pattern of the maternal plasma metabolites and the fetoplacental dysfunction.
    Tanguy G; Thoumsin HJ; Zorn JR; Cedard L
    Gynecol Obstet Invest; 1981; 12(6):305-16. PubMed ID: 6457777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioimmunological determination of unconjugated plasma estradiol and estriol after administration of dehydroepiandrosterone sulfate in late pregnancy].
    Schollberg K; Seiler E; Holtorff J; Köhler B
    Zentralbl Gynakol; 1976; 98(25):1537-46. PubMed ID: 139062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydroepiandrosterone sulfate loading test in the diagnosis of complicated pregnancies.
    Tulchinsky D; Osathanondh R; Finn A
    N Engl J Med; 1976 Mar; 294(10):517-22. PubMed ID: 129704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydroepiandrosterone metabolism.
    Longcope C
    J Endocrinol; 1996 Sep; 150 Suppl():S125-7. PubMed ID: 8943796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal plasma estrogens after dehydroepiandrosterone-sulfate injection into the fetus.
    Gamissans O; Wilson GR; Cuyas J; Davi E; Pujol-Amat P
    Obstet Gynecol; 1977 Oct; 50(4):439-41. PubMed ID: 143623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of endogenous steroid levels with high and low density lipoprotein concentrations in the human maternal-fetoplacental unit at term.
    Nayar S; Reggio BC; Henson MC
    J Reprod Med; 1996 Feb; 41(2):91-8. PubMed ID: 8656421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal considerations. Metabolic clearance rate of maternal plasma dehydroisoandrosterone sulfate.
    Worley RJ; Everett RB; Madden JD; MacDonald PC; Gant NF
    Semin Perinatol; 1978 Jan; 2(1):15-28. PubMed ID: 153584
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of intrauterine fetal growth retardation (IUGR) and placental insufficiency by a dehydroepiandrosterone sulfate (DHAS) loading test.
    Rabe T; Hösch R; Runnebaum B
    Biol Res Pregnancy Perinatol; 1983; 4(3):130-6. PubMed ID: 6226324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of constant infusion of unlabeled dehydroepiandrosterone for the assessment of its metabolic clearance rate, its half-life, and its conversion into estrogens.
    Bélisle S; Schiff I; Tulchinsky D
    J Clin Endocrinol Metab; 1980 Jan; 50(1):117-21. PubMed ID: 6444220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of serum hormone concentrations in maternal and umbilical cord samples.
    Troisi R; Potischman N; Roberts JM; Harger G; Markovic N; Cole B; Lykins D; Siiteri P; Hoover RN
    Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):452-6. PubMed ID: 12750241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-estradiol, dehydroepiandrosterone, and dehydroepiandrosterone sulfate protect against N-methyl-D-aspartate-induced neurotoxicity in rat hippocampal neurons by different mechanisms.
    Kurata K; Takebayashi M; Morinobu S; Yamawaki S
    J Pharmacol Exp Ther; 2004 Oct; 311(1):237-45. PubMed ID: 15175425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The endocrine status of clinically conspicuous mares during the peripartum period].
    Meinecke B; Gips H
    Tierarztl Prax; 1990 Oct; 18(5):513-23. PubMed ID: 2264056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal C19 steroids and serum lipoprotein levels in healthy men.
    Vatalas IA; Dionyssiou-Asteriou A
    Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):388-93. PubMed ID: 12055703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of the DHEA-sulphate-test in pregnancy.
    Bazsa-Kassai Z; Takács I; Körösi T
    Acta Physiol Hung; 1985; 65(4):497-505. PubMed ID: 3160219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.